HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.

Abstract
[reaction: see text] An enantiospecific total synthesis of Weinreb's advanced intermediate 2 for (-)-agelastatin A has been achieved from the Hough-Richardson aziridine 8. Noteworthy reactions in our sequence include the highly regioselective trans-diaxial ring-opening of 8 with azide ion to set up the vicinal diamido functionality present within (-)-2 and the Grubbs-Hoveyda ring-closing metathesis (RCM) reaction that was used to construct its cyclopentene core.
AuthorsKarl J Hale, Mathias M Domostoj, Derek A Tocher, Ed Irving, Feodor Scheinmann
JournalOrganic letters (Org Lett) Vol. 5 Issue 16 Pg. 2927-30 (Aug 07 2003) ISSN: 1523-7060 [Print] United States
PMID12889910 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Oxazolidinones
  • agelastatin A
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
Topics
  • Alkaloids (chemical synthesis, chemistry, pharmacology)
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Enzyme Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Glycogen Synthase Kinase 3 (antagonists & inhibitors)
  • Glycogen Synthase Kinase 3 beta
  • Oxazolidinones (chemical synthesis, chemistry, pharmacology)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: